SCC - SQUAMOUS CELL CARCINOMA
Clinical trials for SCC - SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SCC - SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SCC - SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new treatment called MQ710, made from a modified virus, for people with advanced solid tumors that have not responded to standard therapies. The treatment is injected directly into tumors, either alone or with the immunotherapy drug pembrolizumab. T…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New scan could spot hidden head and neck cancers, reducing unnecessary biopsies
Diagnosis Recruiting nowThis early-phase study tests a new radioactive tracer called [18F]NOTA-ABY030, used with PET/CT scans, to see if it can safely and more accurately detect head and neck cancers that standard scans may miss. About 25 adults with squamous cell carcinoma of the head and neck will rec…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 22, 2026 13:54 UTC
-
Blood test after radiation may spot cancer return early
Knowledge-focused Recruiting nowThis study is for people with advanced head and neck cancer (stage III or IV) who are getting radiation therapy. Researchers want to see if measuring tumor DNA in the blood one month after treatment can help predict whether the cancer will come back within two years. About 188 pa…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated May 26, 2026 04:54 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer
Knowledge-focused Recruiting nowThis early-stage study tests a special dye (IRDye800) attached to the cancer drug panitumumab. The dye makes cancer cells glow under a special camera during surgery, helping doctors see exactly where the cancer is. About 18 adults with head and neck cancer will receive the dye be…
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:52 UTC
-
New scanner could help surgeons spot Left-Behind cancer in real time
Knowledge-focused Recruiting nowThis study is testing a new device that takes detailed PET-CT pictures of a tumor right after it is removed during surgery. The goal is to help surgeons see if any cancer cells are left behind, so they can remove more tissue if needed. About 50 adults with solid tumors will take …
Matched conditions: SCC - SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC